EFM
EVMN

E Fund Management’s Evommune Inc EVMN Stock Holding History

E Fund Management’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.6M Buy
+243,700
New +$5.51M 0.17% 77

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $1.02B AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

E Fund Management's EVMN Position: Q1 2026 in Review

E Fund Management opened a new position in Evommune Inc (EVMN) in Q1 2026: 243,700 shares worth $5.6M. The stake represents 0.17% of the portfolio and ranks #77 among its holdings.

84 funds tracked by Wall St. Rank hold EVMN as of Q1 2026.

  • E Fund Management held 243,700 shares of Evommune Inc worth $5.6M as of Q1 2026.
  • Evommune Inc was a new E Fund Management position in Q1 2026.
  • Evommune Inc made up 0.17% of E Fund Management's portfolio in Q1 2026, its #77 holding.
  • 84 funds tracked by Wall St. Rank held Evommune Inc as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.